|
Market Closed -
Warsaw S.E.
19:55:50 11/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 129.00 PLN | -0.77% |
|
+0.78% | -5.29% |
| 05-27 | Scope Fluidics says Bacteromic granted U.S. patent 'microfluidic chip' | RE |
| 05-15 | Scope Fluidics Q1 net loss at 13.5 million zlotys | RE |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | 223.9 | +72.23% | 1 | ||||
| 25.07 | +3.47% | 7 | ||||||
| 10 | +22.85% | 9 | ||||||
| 58.42 | +38.99% | 12 | ||||||
| 54.14 | +8.24% | 7 | ||||||
| - | - | 51.14 | +40.8% | 1 | ||||
| - | 45,500 | +44.44% | 2 | |||||
| 7.417 | +10.2% | 6 | ||||||
| 8.25 | +107.29% | 4 | ||||||
| Average | 5,104.26 | +38.72% | 5 | ||||||
| Weighted average by Cap. | 2,743.92 | +23.18% | 7 |
- Stock Market
- Stocks
- SCP Stock
- Sector Scope Fluidics S.A.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
